Search

A study conducted at University Medical Center Regensburg in Germany explored the potential benefits of combining cold atmospheric plasma (CAP) with photodynamic therapy (PDT) using 5-aminolevulinic acid (ALA) for the treatment of squamous cell carcinoma (SCC) cells. The research found that the combined treatment showed improved efficacy in SCC cells, with increased expression of apoptosis- and senescence-related molecules. However, normal human epidermal keratinocytes (HEKn) were less affected by the treatment. Further studies are needed to determine the effectiveness of this combined approach in treating actinic keratosis (AK) in vivo. [Extracted from the article]

Researchers from Xi'an Jiaotong University in China have explored the potential synergies between metal-organic frameworks (MOFs) and cold atmospheric plasmas (CAPs) for cancer treatment. MOFs offer unique characteristics that make them promising for cancer therapy, but concerns about biosafety have hindered their clinical use. The study suggests that combining MOFs with CAPs could enhance treatment efficacy by utilizing MOFs as cargo-carriers, nano-enzymes, and magnetic agents. This research, published in the Journal of Materials Chemistry B, highlights a novel approach that may revolutionize the field of plasma medicine and expand the applications of MOFs in cancer control. [Extracted from the article]

A recent report from Anhui University of Science and Technology highlights the innovative use of Cold Atmospheric Plasma (CAP) technology in dermatology and skincare. CAP has shown significant antimicrobial properties, promotes tissue proliferation and wound healing, and inhibits tumor cell growth. The research emphasizes CAP's potential in treating various skin conditions and immune-mediated skin diseases, offering a safe and effective approach. Further research is needed to fully understand CAP's mechanisms and expand its clinical applications. [Extracted from the article]

Researchers from the University Medical Centre Regensburg in Germany conducted a study on the effects of pressure, hypoxia, and hyperoxia on neutrophil granulocytes. The study found that normo- and hyperbaric oxygen therapy can impact the functionality and surface epitopes of neutrophils, which may have implications for disorders involving these cells. The research suggests that careful consideration and handling of oxygen in clinical practice is crucial, especially in hyperbaric experiments. The study was published in Biomolecules and can be accessed for free online. [Extracted from the article]

A study conducted by researchers at Shizuoka University in Japan explores the potential of cold atmospheric plasma (CAP) in facilitating the delivery of large-molecule drugs to the brain. The blood-brain barrier (BBB) typically restricts the passage of most drugs, making it challenging to treat neurological disorders. The study found that CAP generates reactive oxygen and nitrogen species (RONS) that may disrupt the BBB's tight junctions, potentially increasing drug permeability. These findings suggest that CAP could be a promising approach for enhancing brain drug delivery. [Extracted from the article]

A recent study conducted by the Department of Food Science and Technology explored the effects of Origanum onites essential oil (OEO) and cold atmospheric plasma (CAP) on the quality of Iranian white cheese during storage. The researchers found that OEO exhibited antioxidant and antimicrobial properties, and when combined with CAP, it could induce microbial growth and oxidative reactions in the cheese. The study evaluated various parameters such as pH, color indexes, microbial count, and sensory properties of the cheese samples over a 45-day period. The findings suggest that a combination of OEO (2500 ppm) and CAP (3 min) could be beneficial for the quality of Iranian white cheese. [Extracted from the article]

Researchers from Xi'an Jiaotong University in China have explored the potential use of magnetic nanoparticles (MNPs) in cancer treatment. MNPs have unique properties that make them attractive for biomedical applications, but there are still challenges to overcome, such as low therapeutic efficacy and safety concerns. The researchers propose that cold atmospheric plasma (CAP) could enhance the effectiveness of MNPs by generating free radicals, reducing hyperthermia resistance, preventing MNP aggregation, and serving as a magnetic and light source for magnetothermal- and photo-therapies. This study provides insights into the possible synergies between MNPs and CAP, which could inspire further research in this field. [Extracted from the article]

A recent study conducted by the Medical University of Vienna in Austria explored the use of cold atmospheric plasma (CAP) therapy as a potential treatment for pediatric cannula infections in Berlin Heart EXCOR patients. The study found that CAP therapy was safe and effective in treating one pediatric patient with cannula exit-site wound healing disorders, resulting in visible improvements in wound staging, reduction in bacterial load, and inflammatory parameters. However, further research is needed to investigate this therapy in more detail. The study was published in the journal Artificial Organs and has undergone peer-review. [Extracted from the article]

A study conducted by researchers at Xi'an Jiaotong University in Shaanxi, China, has developed a new treatment for psoriasis using plasma-activated ice microneedle patches. These patches deliver reactive oxygen and nitrogen species (RONS) to the skin, which help reduce inflammation and treat psoriasis. The patches were found to be effective in treating psoriasis in mice without causing any systemic toxicity. This research offers a potential alternative to direct cold atmospheric plasma (CAP) irradiation treatment for psoriasis. [Extracted from the article]

A recent study conducted at the University Medical Center Regensburg in Germany investigated the use of cold atmospheric plasma (CAP) treatment in the upper respiratory tract (URT) to reduce the incidence of ventilator-associated bacterial pneumonia and viral infections, such as COVID-19. The study found that a 5-minute CAP treatment with the plasma intensive care (PIC) device did not cause any significant cell damage in human oral keratinocytes, human bronchial-tracheal epithelial cells, and human lung fibroblasts. However, it did induce the production of pro-inflammatory cytokines and profibrotic molecules at the mRNA level. The researchers concluded that while the treatment did not cause cell damage, further studies are needed to examine immune cell activation and potential long-term effects. [Extracted from the article]

A recent study conducted in Haslemere, United Kingdom, explored the antimicrobial efficacy of grape seed extract (GSE) and cold atmospheric plasma (CAP) individually and in combination against foodborne pathogens and their environmental stress knockout mutants. The researchers found that a synergistic effect was achieved when GSE exposure was followed by CAP treatment. They also discovered that certain mutants were more sensitive to GSE or CAP individually. The study provides insights into the mechanisms of bacterial resistance and contributes to the development of more effective antimicrobial strategies for sustainable decontamination. [Extracted from the article]

A recent report discusses research on neurofibromatosis type 1 (NF1), an autosomal dominant disorder caused by mutations in the NF1 gene. The study focused on the effects of cold atmospheric plasma (CAP) on NF1-associated peripheral nerve sheath tumors (PNSTs). The researchers found that NF1-associated PNSTs were highly sensitive to CAP exposure, resulting in cell death. This study provides a unique opportunity to study the complex biology of NF1-associated tumors and offers potential for more effective therapies for these aggressive malignancies. [Extracted from the article]

Researchers at the Federal Rural University of the Semiarid Region in Mossoro, Brazil, have conducted a study on the effects of a combined treatment for self-traumatic chronic skin lesions associated with post-surgical neuropathic pain in a domestic cat. The treatment involved the use of cold atmospheric plasma (CAP) along with pharmacological interventions. The results showed significant healing of the skin lesions and improvement in the cat's quality of life. This research provides valuable insights into potential treatment options for similar conditions in animals. [Extracted from the article]

Researchers at the University of Freiburg Medical Center in Germany have found that cold atmospheric plasma (CAP) may be a promising alternative to antibiotics in dentistry. The researchers tested the antimicrobial efficacy of CAP on aerobic and anaerobic bacteria relevant to dentistry and found that it effectively killed the bacteria without causing resistance or patient discomfort. The researchers concluded that CAP could be used as a clinical therapeutic treatment for eliminating pathogenic oral bacteria. This research was supported by the Federal Ministry of Education And Research. [Extracted from the article]

A recent study conducted by researchers at North Carolina State University explores the potential of cold atmospheric plasma (CAP) as a treatment for fungal keratitis, a severe corneal disease. The study focuses on the efficacy of CAP against two common fungal pathogens, Aspergillus flavus and Fusarium keratoplasticum. The researchers found that CAP effectively reduced fungal viability in both biofilm and conidial suspension cultures of these pathogens, suggesting that it could be a promising alternative treatment strategy for fungal keratitis. This research was supported by the Boehringer Ingelheim 2023 Advancement in Equine Research Award. [Extracted from the article]

The article reports the issuance of a patent to Clear Intradermal Technologies Inc. for a novel tattoo removal method utilizing a liquid-gas mixture with plasma gas bubbles. Topics discussed include the limitations of current laser-based tattoo removal methods, the advantages of the new plasma-based approach in reducing pain and scarring, and the technical details of the patent's liquid-gas plasma application for dislodging and extracting tattoo ink particles.

The article focuses on the development of a noninvasive imaging technique for monitoring plasma-induced skin inflammation. Topics include the use of cold atmospheric plasma (CAP) to generate reactive oxygen species (ROS), the creation of a skin-inflammation model in mice, and the application of dynamic nuclear polarization-MRI (DNP-MRI) to track redox changes and inflammation progression.

A patent has been issued to the Jerome Canady Research Institute for Advanced Bio for a method of treating cancer using a combination of cold atmospheric plasma and a gene inhibitor. The patent describes the use of cold atmospheric plasma to induce apoptosis in cancer cells, particularly in triple-negative breast cancer cells. The method involves treating the patient with a gene inhibitor before, during, and after surgery to inhibit the upregulation of a specific gene, and applying cold atmospheric plasma to the surgical margins. The patent suggests that this combination therapy could improve the prognosis for patients with triple-negative breast cancer. [Extracted from the article]

Researchers at Xi'an Jiaotong University in Shaanxi, China have conducted a study on the anticancer effects of plasma-activated hydrogel on melanoma cells. The study found that the hydrogel had a sustained and effective anticancer effect, prolonging the storage duration of reactive species and inducing melanoma cell apoptosis. In contrast, plasma-activated saline had a less potent anticancer effect. The researchers concluded that the hydrogel could serve as a useful carrier for reactive species and has potential for further anticancer research. This research has been peer-reviewed and published in Plasma Processes and Polymers. [Extracted from the article]

Researchers at Xi'an Jiaotong University in Shaanxi, China have conducted a study on the anticancer effects of cold atmospheric plasma (CAP) therapy on deep subcutaneous tumor cells. The study found that plasma-irradiated normal cells released soluble factors that selectively killed nonirradiated cancer cells. The release of these factors was mediated by short-lived species generated by the plasma. The researchers concluded that CAP-induced anticancer effects can be transmitted to cancer cells through normal cells. This research has been peer-reviewed and provides valuable insights into the potential of CAP therapy for cancer treatment. [Extracted from the article]

A clinical trial, NCT06529159, is being conducted to investigate the effectiveness and safety of a new therapy called H. Pylori Eradication With Argon Plasma During Endoscopy (HEAPE) for treating H. pylori infections during endoscopic procedures. The therapy involves using argon plasma coagulation (APC) to reduce H. pylori levels in the stomach. The trial aims to evaluate the immediate effect of the treatment using a urea breath test and assess the safety and effectiveness of the therapy in eradicating or reducing H. pylori in humans. The study is being conducted by Brigham and Women's Hospital in collaboration with Erbe Elektromedizin GmbH. [Extracted from the article]

A recent report discusses the research conducted at the Medical University of Sofia in Bulgaria on the potential of a novel microwave plasma source for enhancing wound healing in diabetic individuals. The study found that the treated group exhibited accelerated wound closure compared to the control group, suggesting that cold atmospheric plasma (CAP) has the potential to enhance the healing process. The research concluded that CAP has a multifaceted impact on the wound healing cascade, promoting angiogenesis, modulating inflammatory responses, and exhibiting antimicrobial properties. These findings position CAP as a promising intervention in acute wound management, with further exploration of its therapeutic potential in clinical settings warranted. [Extracted from the article]

A patent application has been published for a needle adaptor that can be used with a plasma generating handpiece to remove tattoos. The adaptor allows plasma to be delivered to the tip of the needle, which can degrade and remove tattoo ink particles in the skin. The adaptor can accommodate different types of needles and can be disposable or re-sterilizable. The method involves connecting the adaptor to the handpiece, attaching needles, connecting a fluid supply line, placing the needles at the tattooed area, delivering fluid through the energy conductor, and activating the handpiece to generate plasma at the needle tips. Pretreatment and post-treatment steps can also be performed. [Extracted from the article]

Researchers from Capital Medical University in Beijing, China have conducted a study on the biosafety of periodontal ligament fibroblasts induced by cold atmospheric plasma (CAP) in vitro. The study aimed to evaluate the cytotoxicity, genotoxicity, and mechanisms of human periodontal ligament fibroblasts (hPDLFs) when exposed to CAP. The results showed that CAP had a significant inhibitory effect on Porphyromonas gingivalis (P. gingivalis) after 6 minutes of treatment. The study concluded that these effects were primarily due to the formation of reactive oxygen and nitrogen species (RONS). [Extracted from the article]

A recent report from Wroclaw University of Science and Technology in Poland discusses the potential of cold atmospheric pressure plasmas (CAPPs) for degrading organic pollutants derived from the food production industry. The study highlights the use of specialized chemicals in food production, such as antibiotics and pesticides, which can have negative effects on the ecosystem. CAPP-based technologies are presented as promising solutions for the removal of these pollutants, offering eco-friendliness and efficiency. The research emphasizes the importance of optimizing CAPP operating parameters and considers the biological and environmental effects of these treatments. [Extracted from the article]

A report from Xi'an Jiaotong University in China discusses the clinical relevance of glycosylation in cancer diagnosis and therapeutics. The researchers highlight the connection between glycosylation and cellular redox status and propose the use of redox modulatory tools, such as cold atmospheric plasma (CAP), in cancer control through glycosylation editing. The study suggests that glycosylation editing could be an innovative therapeutic opportunity in precision oncology. The research has been peer-reviewed and provides new insights for laboratory practice and precision oncology therapy. [Extracted from the article]

A recent report from Nicolaus Copernicus University in Torun highlights the potential of cold atmospheric plasma (CAP) therapies in modern medicine. CAP, a partially or fully ionized gas, has unique properties that make it suitable for medical applications. It has antimicrobial properties, enhances cell proliferation and tissue regeneration, and shows promise in anti-tumor therapies, stem cell proliferation, dental applications, and neurology. The objective of the study is to provide a comprehensive overview of CAP applications in multiple medical conditions and to highlight its potential as a novel treatment modality. The researchers aim to gather evidence in favor of CAP therapy and provide a convenient reference source for readers interested in exploring its potential in medicine. [Extracted from the article]

A recent report from Chiang Mai University in Thailand discusses the use of atmospheric nonthermal plasma (ANTP) in biomedicine, particularly in treating skin diseases. The study aimed to investigate the adverse effects of ANTP on genetic substances in murine fibroblast cells. The researchers found that exposure to ANTP led to reduced cell viability and proliferation, increased reactive species in the cells, and significant DNA damage. While ANTP was not classified as a mutagen in the Ames test, the study highlights the genotoxic and mutagenic effects of ANTP and emphasizes the need for cautious selection of plasma intensity to avoid adverse side effects. [Extracted from the article]

A recent study conducted by researchers at the University of Bath in the United Kingdom has explored the use of silver in wound care. While silver is effective at controlling the growth of bacteria commonly found in wounds, it can also be cytotoxic and hinder the healing process. The researchers developed a composite hydrogel that can release silver on demand when exposed to a cold atmospheric plasma jet. The released silver was found to inhibit the growth of certain bacteria and reduce the viability of biofilms. This research provides new insights into wound infection control. [Extracted from the article]

A recent study conducted by the Leibniz Institute for Plasma Science and Technology in Greifswald, Germany explored the influence of cold plasma on epidermal melanogenesis, the process of melanin synthesis that determines an individual's skin color. The researchers used a plasma jet called kINPen(R) MED and evaluated its impact on melanin synthesis in both cultured human melanocytes (in vitro) and full-thickness human skin biopsies (in situ). The study found that repeated exposure to cold plasma increased the melanin content in skin biopsies, but had only minor effects on cultured melanocytes. The researchers concluded that cold plasma may not be a useful option for treating skin pigmentation disorders, but the risk of hyperpigmentation as an adverse effect of cold plasma application for wound healing or other dermatological diseases seems to be negligible. [Extracted from the article]

A patent application for a robotic cold atmospheric plasma surgical system and method has been filed by inventors Canady, Jerome; Jun, Changhan; and Zhuang, Taisen. The invention aims to provide a system and method for controlling a dosage of cold plasma generated multi-species delivered to a patient during surgery. The system utilizes a robotic arm to move a cold atmospheric plasma probe over a defined tissue area, while maintaining a constant distance from the tissue and applying cold atmospheric plasma treatment. The invention also includes a passive positioning system, a master control module, and a cold atmospheric plasma generator. [Extracted from the article]

A study conducted by researchers at Gachon University in South Korea examined the antibacterial efficacy of cold atmospheric plasma (CAP) on oral microcosm biofilms and the impact of biofilm maturity on treatment. The researchers found that as biofilms mature, their biomass and extracellular polysaccharide (EPS) content increase, making them more pathogenic. However, CAP treatment was effective in maintaining antibacterial efficacy regardless of the biofilm development stage, suggesting its potential use in oral care. This research was supported by the National Research Foundation of Korea. [Extracted from the article]

A recent study conducted at the University of Cincinnati explores the potential of cold atmospheric plasma (CAP) in cancer therapy and virus inactivation. CAP has been shown to selectively target cancer cells, triggering apoptosis and inhibiting tumor growth while sparing healthy cells. Additionally, CAP has antimicrobial properties that make it effective in virus inactivation. The study examines the effects of CAP treatment on B16 melanoma cells and explores its potential in enhancing the therapeutic efficacy of a mitochondrial modulator called dichloroacetate (DCA) on melanoma apoptosis. The study also investigates CAP's proficiency in deactivating SARS-CoV-2 on various surfaces, suggesting its potential as a surface disinfection strategy. [Extracted from the article]

A patent has been issued for a system and method for voice-control of an electrosurgical system. The system includes an electrosurgical generator, a controller with a memory, a graphical user interface, a power module, a field programmable gate array, and a speech recognition module. The system allows for voice commands to be given to electrical operating room equipment, such as the electrosurgical generator or a robotic surgical system, and the commands are encrypted and decrypted for safety. The patent was filed by inventors Jerome Canady, Changhan Jun, and Taisen Zhuang, and the assignee is the Jerome Canady Research Institute. [Extracted from the article]

A recent study conducted at Shandong University in China has used machine learning technology to uncover the interaction mechanisms between cold atmospheric plasma (CAP) and amino acids. CAP has shown potential in various medical applications, but its underlying mechanisms are not well understood. The researchers used reactive molecular dynamics simulations and a deep neural network to predict oxidative modifications and the probability of their occurrence. This study demonstrates the potential of machine learning in efficiently uncovering the mechanisms of plasma medicine. [Extracted from the article]

A recent study conducted by researchers at Islamic Azad University in Tehran, Iran, explored the effects of recombinant basic fibroblast growth factor (bFGF) and cold atmospheric plasma (CAP) on the healing and regeneration of calcaneus tendons in rabbits. The study divided 40 male New Zealand white rabbits into four groups, each receiving a different treatment or no treatment at all. The researchers used stains and measured hydroxyproline levels to evaluate collagen production and tissue factors. The results showed that the combination of bFGF and CAP significantly improved tendon remodeling in the injured areas. [Extracted from the article]

A patent has been issued to the Jerome Canady Research Institute for Advanced Biological and Technological Sciences for a system and method that combines cold atmospheric plasma treatment with radiation and chemotherapy for the treatment of colon cancer. The patent describes the background of colorectal cancer and the limitations of current treatments. The invention aims to provide a novel treatment approach for peritoneal carcinomatosis secondary to colon cancer using cold atmospheric plasma in combination with chemotherapy, radiation, and cytoreductive surgery. The patent also discusses the potential benefits of cold atmospheric plasma treatment in biomedical technology. [Extracted from the article]

A new report from Fuzhou University in China discusses the treatment of androgenetic alopecia (AGA), a form of hair loss. The researchers propose a multi-synergistic therapeutic platform that combines microneedle patches loaded with minoxidil-encapsulated nanostructured lipid carriers (MXD-NLC-MNs) and cold atmospheric plasma (CAP). This combination therapy aims to reshape the perifollicular microenvironment and promote hair regeneration. The researchers believe that this strategy shows promise for effectively treating AGA and promoting hair regrowth. [Extracted from the article]

A patent has been issued for a new system and method that combines cold plasma and high frequency plasma for various biomedical applications. This technology has potential uses in sterilization, wound healing, and cancer therapy. By utilizing low and high frequency electrosurgical units, a resonant transformer, and an inert gas, the system can generate cold atmospheric plasma. This innovation shows promise in selectively killing cancer cells while leaving normal cells unharmed, offering a potential new approach to cancer treatment. The article provides fact-based information on recent research and discoveries in the field of pharmaceuticals, covering topics such as cancer, surgery, dentistry, drugs and therapies, and health and medicine. [Extracted from the article]

Researchers from the University of Mazandaran in Iran have conducted a study on the potential use of cold atmospheric plasma technology in neuroprotection. The study suggests that low levels of reactive oxygen species (ROS) and reactive nitrogen species (RNS) can stimulate growth and development and have protective effects on brain cells. Cold atmospheric plasma has shown promising results in various biomedical applications, including cell growth, proliferation, and protection against oxidative stress. The researchers propose that this technology could be a potential therapeutic strategy for protecting neurons against central nervous system (CNS) damage. The study focuses on the regeneration and neuroprotection effects of cold atmospheric plasma in treating neurological injuries. [Extracted from the article]

A study conducted by researchers at the Universidad Austral de Chile examined the use of cold atmospheric plasma (CAP) treatment on acid-tolerant Listeria strains found in fresh blueberries. The study found that CAP treatments of 30 seconds or longer resulted in significant reductions in pathogens, including Listeria monocytogenes. Additionally, the study concluded that CAP is an effective antimicrobial treatment that does not significantly affect the quality of the fruit. This research provides valuable insights into potential methods for reducing contamination and spoilage in delicate fruits like blueberries. [Extracted from the article]

Researchers at Saarland University in Germany have conducted a study on the effects of cold atmospheric plasma (CAP) treatment on titanium surfaces and the colonization of primary human osteoblasts. The study found that plasma treatment improved the initial attachment of osteoblasts to titanium, indicating the potential for using CAP in implantology. The research supports the use of CAP for preimplantation conditioning and regeneration of lost attachment due to peri-implantitis. The study demonstrates the biocompatibility of micro-structured titanium and provides valuable insights for future research in this field. [Extracted from the article]

A recent study conducted by researchers at Islamic Azad University in Tehran, Iran, explored the use of cold atmospheric plasma torch (CAPT) in reducing microbial load and maintaining sensory properties in ready-to-eat Olivier salad. The study found that reducing the distance between the CAPT nozzle and the salad surface, as well as increasing the treatment time, effectively reduced the microbial load. The most successful treatment was found to be at a 3 cm distance for 90 seconds, which achieved both microbial reduction and high acceptability in sensory evaluations. The research suggests that CAPT could be a successful method for improving the safety of ready-to-eat products. [Extracted from the article]

A study conducted at Islamic Azad University in Tehran, Iran, evaluated the effects of dielectric barrier discharge (DBD) plasma on Candida albicans, a fungus that causes candidiasis. The researchers found that a 10-minute exposure to DBD plasma, both with and without the antifungal drug nystatin, resulted in the lowest viability of C. albicans cells. The combination of 10-minute DBD plasma irradiation with nystatin was more effective in reducing the survival rate of C. albicans compared to other exposure times. This research provides insights into the potential use of DBD plasma as an alternative treatment for antifungal-resistant candidiasis. [Extracted from the article]

A recent study conducted by researchers at the University of Coimbra in Portugal examined the efficacy of cold atmospheric plasma (CAP) compared to chemotherapy in treating triple-negative breast cancer (TNBC). The researchers conducted a systematic review of studies that evaluated the effects of chemotherapy and CAP on TNBC cell lines and animal models. They found that both treatments resulted in a decrease in cell proliferation and a reduction in tumor volume in vivo. The study suggests that CAP may be a successful treatment for TNBC, with apoptosis being the predominant type of cellular death. Further research is needed to fully understand the potential of CAP in breast cancer treatment. [Extracted from the article]

Researchers from Soonchunhyang University in Cheonan Si, South Korea have conducted a study on the use of cold atmospheric plasma in the treatment of chronic wounds. They found that a custom-made plasma device promoted faster wound healing in a mouse model, with improved epithelialization, collagen maturation, and reduced inflammation. The study suggests that floating electrode-dielectric barrier discharge-based plasma could be a potential therapeutic option for various wounds. The research has been peer-reviewed and provides valuable insights into the field of biomedical engineering. [Extracted from the article]

A new study conducted by researchers at the Federal University of Rio Grande do Norte in Brazil explores a method for enhancing the performance of titanium dental implants. The study introduces a treatment using cold atmospheric plasma (CAP) on titanium surfaces within sealed packaging. The researchers found that the CAP treatment resulted in improved platelet activation, platelet density, and thrombus formation, as well as reduced bacterial colony formation. The study concludes that this innovative method shows promise for advancing osseointegration and bacterial resistance in dental implants. [Extracted from the article]

A recent study conducted by researchers at the First Affiliated Hospital of Xi'an Jiaotong University in China has explored the potential use of cold atmospheric plasma (CAP) as a treatment for chronic kidney disease (CKD)-related skin disorders. The study found that CAP showed promise in mitigating skin atrophy, hydration dysfunction, and inflammation in mice with CKD. Skin biopsies from both CKD patients and mice revealed pathological changes such as stratum corneum thickening, epidermis atrophy, and excessive inflammation. These findings suggest that CAP could be a novel therapeutic avenue for the treatment of CKD-related skin disorders. [Extracted from the article]

A report from Xiamen University in China discusses the potential of cold atmospheric plasma (CAP) as an emerging immunomodulatory therapy. CAP generates reactive oxygen and nitrogen species, electric fields, and UV radiation, and has shown promise in regulating the immune system. It has potential applications in wound healing, cancer treatment, and infection control. The review highlights CAP's impact on cytokine production, immune cell phagocytosis, and immune cell proliferation. Further research is needed to understand the mechanisms underlying CAP's effects and optimize its clinical application. CAP has potential therapeutic benefits in disinfection, wound healing, dental care, blood clotting, and cancer treatment. [Extracted from the article]

A preprint abstract from osf.io discusses the combined effect of cold atmospheric plasma (CAP) and a static magnetic field (SMF) on the treatment of MDA-MB-231 breast cancer cells. The study found that the presence of the SMF and vitamin C, as well as increasing the input power, significantly reduced the survival and migration rate of the cells. These findings suggest that using the SMF and vitamin C as a complement to conventional CAP therapies could improve the efficacy of CAP in cancer therapy. It is important to note that this preprint has not been peer-reviewed. [Extracted from the article]